drugset
drugset / Trial / NCT03559166

First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

NCT03559166 ↗

Phase 1 Completed 88 enrolled Blade Therapeutics
RandomizedSequentialQuadruple-blindTreatment

Summary

First in Human single ascending dose followed by multiple ascending doses in healthy volunteers.

Timeline

Start
2018-07-11
Primary completion
2019-10-04
Completion
2019-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject DAZCAPISTAT Small molecule — Oral

Indications

No indication recorded.